• Cy3 RNA Labeling Kit: HyperScribe™ T7

  2026-08-14

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based research workflows. It is intended for applications such as in situ hybridization and Northern blotting, but it is not for diagnostic, therapeutic, or medical use.

• T7 RNA Polymerase for Translational RNA Workflows

  2026-08-14

  T7 RNA Polymerase converts promoter-bearing DNA into research-grade RNA for vaccine design, antisense studies, RNAi, and functional assays. This guide connects template engineering and reaction optimization with the comparative mRNA vaccine findings reported for varicella-zoster virus glycoprotein E.

• Morin Workflows for Mitochondrial and Fluorescent Assays

  2026-08-13

  Morin connects mechanistic studies of oxidative stress, inflammation, and podocyte energy metabolism with a practical fluorescent aluminum-ion assay. This guide translates those properties into reproducible workflows, control strategies, and troubleshooting steps while keeping preclinical findings distinct from clinical conclusions.

• DFO: From Latent Prints to Assay-Smart Fluorescence

  2026-08-13

  DFO (9H-1,8-Diazafluoren-9-one) is a fluorescent reagent for amino-acid-based latent fingerprint detection on porous evidence. This article connects its forensic chemistry with modern assay-design lessons from a zebrafish ferroptosis study while clearly defining the limits of that cross-domain comparison.

• Cy3 TSA Fluorescence System Kit Workflow

  2026-08-12

  Translate weak protein and lncRNA signals into localized Cy3 fluorescence for IHC, ICC, and ISH. This practical workflow connects tyramide signal amplification with the Lnc21q22.11 gastric cancer study and emphasizes assay design, quantitative imaging, and troubleshooting rather than unsupported fold-change claims.

• Bufalin: From Binding to STK33 Degradation

  2026-08-12

  Bufalin is a cardiotonic steroid whose value in modern oncology research extends beyond cytotoxicity. This article presents a mechanistic framework for connecting target engagement, STK33 degradation, apoptosis, and translational assay interpretation in triple-negative breast cancer research.

• Metformin HCl: From Metabolic Control to Tendon Biology

  2026-08-11

  Metformin Hydrochloride is more than a glucose-metabolism research tool. This thought-leadership analysis connects AMPK, redox, and lipid-regulatory biology with emerging evidence that metformin suppresses Achilles tendon heterotopic ossification through the Nr4a1/Wnt/β-catenin axis, while outlining practical validation and translational strategy.

• Gut Microbial H2S, GLP-1, and Metabolic Dysfunction

  2026-08-11

  A 2024 Nature Metabolism study identifies Desulfovibrio-derived hydrogen sulfide as a gut-to-host signal that suppresses GLP-1 production in male mice. By connecting microbial dysbiosis with mitochondrial respiration, the unfolded protein response, and enteroendocrine L-cell function, the work provides a mechanistic framework for understanding how harmful microbial metabolites contribute to metabolic syndrome.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide

  2026-08-10

  Build bright, tunable RNA probes for spatial and membrane-based assays with a workflow that balances Cy3-UTP incorporation against transcription yield. This practical guide connects MALAT1 pathway research with in situ hybridization and Northern blot fluorescent probe design while emphasizing controls and troubleshooting.

• Metformin HCl: From Metabolism to Ossification

  2026-08-09

  Metformin Hydrochloride is more than a glucose-metabolism tool: it offers a mechanistically informative way to study AMPK, redox control, and aberrant tendon ossification. This article presents a pathway-to-phenotype framework for designing stronger metabolic and heterotopic ossification assays.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit Workflow

  2026-08-08

  Turn a sequence-defined DNA template into a tunable fluorescent RNA probe for FISH, in situ hybridization, and Northern blotting. This workflow emphasizes Cy3-UTP ratio control, assay-specific validation, and practical troubleshooting rather than one-size-fits-all labeling.

• Fosinopril Sodium: ACE Inhibition Workflows

  2026-08-07

  Fosinopril sodium combines nanomolar ACE inhibition with a prodrug design that is especially useful for linking biochemical assays to blood pressure, cardiac, and renal endpoints. This practical guide covers solution preparation, assay selection, pharmacokinetic sampling, and troubleshooting for reproducible hypertension research.

• AZD1390: ATM Kinase Inhibitor Workflows for Cancer Research

  2026-08-07

  AZD1390 empowers cancer researchers to dissect DNA repair and radiosensitization with nanomolar precision. Leveraging new insights into G-quadruplex tolerance and ATM pathway modulation, this guide details optimized protocols, troubleshooting, and advanced applications for glioma and lung cancer models.

• Trelagliptin Succinate in Diabetes Research: Protocols & Ins

  2026-08-06

  Trelagliptin succinate (SYR-472 succinate) offers unique value in type 2 diabetes research by combining potent, selective DPP-4 enzyme inhibition with broad pathway modulation. This article translates recent breakthroughs and experimental best practices into actionable workflows, troubleshooting know-how, and comparative perspectives for metabolic and beyond-metabolic studies.

• P/Q-type Calcium Channel Blockade Reduces Ischemic Brain Inj

  2026-08-06

  This study demonstrates that a-eudesmol, a blocker of ω-agatoxin IVA-sensitive P/Q-type Ca2+ channels, significantly attenuates glutamate release and brain damage following focal ischemia in rats. The findings clarify the involvement of Cav2.1 channels in ischemic excitotoxicity and support precise channel inhibition as a neuroprotective strategy.

16097 records 1/1074 page Next 12345 下5页 Last page